Back to Search
Start Over
Increased Expression of Growth Hormone-Releasing Hormone in Fibrinous Inflammation of Proliferative Diabetic Retinopathy.
- Source :
-
American journal of ophthalmology [Am J Ophthalmol] 2020 Jul; Vol. 215, pp. 81-90. Date of Electronic Publication: 2020 Feb 14. - Publication Year :
- 2020
-
Abstract
- Purpose: To investigate the involvement of growth hormone-releasing hormone (GHRH) - growth hormone (GH) signaling in pathogenesis of proliferative diabetic retinopathy (PDR).<br />Design: Experimental laboratory study.<br />Methods: Vitreous humor, aqueous humor, and serum were obtained from 36 eyes of 36 patients with or without type 2 diabetes from 2017 to 2019. For histologic examination, 6 fibrovascular membranes were excised from eyes with active PDR. Three fibrovascular membranes were excised from nondiabetic patients with proliferative vitreoretinopathy (PVR) as controls.<br />Results: In PDR, the fibrovascular tissues consisted of a mature region containing fibrocytes, and an immature region populated by abundant polymorphonuclear leukocytes in a fibrinogen meshwork. Clusters of leukocytes were found adhering to the vascular walls. In PVR, no fibrinogen and polymorphonuclear leukocyte was observed in the fibrovascular membranes. The levels of GHRH and GH in PDR were significantly increased (P < .001), with 1.8-fold and 72.8-fold in vitreous humor, and 2-fold and 4.9-fold in aqueous humor, respectively, when compared with corresponding levels in controls. No significant difference was detected for insulin-like growth factor-1. Immunohistochemistry showed intense expression of GHRH and its receptor GHRH-R in polymorphonuclear leukocytes, vascular endothelial cells, and fibrocytes in fibrovascular membranes of PDR. GHRH staining was not detectable in infiltrating cells within the fibrovascular membrane of PVR.<br />Conclusions: These findings reveal a possible involvement of GHRH/GHRH-R in fibrinous inflammation that might contribute to the formation of fibrovascular membrane in PDR through mediating activities of leukocytes, vascular endothelial cells, and fibrocytes. Targeting GHRH/GHRH-R may be considered as a potential therapeutic approach for the treatment of PDR.<br /> (Copyright © 2020 Elsevier Inc. All rights reserved.)
- Subjects :
- Adult
Aged
Diabetes Mellitus, Type 2 metabolism
Endothelium, Vascular metabolism
Enzyme-Linked Immunosorbent Assay
Female
Fibroblasts metabolism
Humans
Male
Middle Aged
Neutrophils metabolism
Aqueous Humor metabolism
Diabetic Retinopathy blood
Growth Hormone-Releasing Hormone blood
Inflammation blood
Receptors, Neuropeptide blood
Receptors, Pituitary Hormone-Regulating Hormone blood
Vitreous Body metabolism
Subjects
Details
- Language :
- English
- ISSN :
- 1879-1891
- Volume :
- 215
- Database :
- MEDLINE
- Journal :
- American journal of ophthalmology
- Publication Type :
- Academic Journal
- Accession number :
- 32061756
- Full Text :
- https://doi.org/10.1016/j.ajo.2020.02.006